1147 related articles for article (PubMed ID: 21819547)
1. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
; Ampofo WK; Baylor N; Cobey S; Cox NJ; Daves S; Edwards S; Ferguson N; Grohmann G; Hay A; Katz J; Kullabutr K; Lambert L; Levandowski R; Mishra AC; Monto A; Siqueira M; Tashiro M; Waddell AL; Wairagkar N; Wood J; Zambon M; Zhang W
Influenza Other Respir Viruses; 2012 Mar; 6(2):142-52, e1-5. PubMed ID: 21819547
[TBL] [Abstract][Full Text] [Related]
2. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
Abelin A; Colegate T; Gardner S; Hehme N; Palache A
Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
[TBL] [Abstract][Full Text] [Related]
3. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
[TBL] [Abstract][Full Text] [Related]
4. FAO-OIE-WHO Joint Technical Consultation on Avian Influenza at the Human-Animal Interface.
Anderson T; Capua I; Dauphin G; Donis R; Fouchier R; Mumford E; Peiris M; Swayne D; Thiermann A
Influenza Other Respir Viruses; 2010 May; 4 Suppl 1(Suppl 1):1-29. PubMed ID: 20491978
[TBL] [Abstract][Full Text] [Related]
5. The WHO global influenza surveillance and response system (GISRS)-A future perspective.
Hay AJ; McCauley JW
Influenza Other Respir Viruses; 2018 Sep; 12(5):551-557. PubMed ID: 29722140
[TBL] [Abstract][Full Text] [Related]
6. Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.
Criado MF; Sá E Silva M; Lee DH; Salge CAL; Spackman E; Donis R; Wan XF; Swayne DE
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999029
[TBL] [Abstract][Full Text] [Related]
7. WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011.
Klimov AI; Garten R; Russell C; Barr IG; Besselaar TG; Daniels R; Engelhardt OG; Grohmann G; Itamura S; Kelso A; McCauley J; Odagiri T; Smith D; Tashiro M; Xu X; Webby R; Wang D; Ye Z; Yuelong S; Zhang W; Cox N;
Vaccine; 2012 Oct; 30(45):6461-71. PubMed ID: 22917957
[TBL] [Abstract][Full Text] [Related]
8. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production.
Dong J; Matsuoka Y; Maines TR; Swayne DE; O'Neill E; Davis CT; Van-Hoven N; Balish A; Yu HJ; Katz JM; Klimov A; Cox N; Li DX; Wang Y; Guo YJ; Yang WZ; Donis RO; Shu YL
Influenza Other Respir Viruses; 2009 Nov; 3(6):287-95. PubMed ID: 19903211
[TBL] [Abstract][Full Text] [Related]
9. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
[TBL] [Abstract][Full Text] [Related]
10. A ten-year China-US laboratory collaboration: improving response to influenza threats in China and the world, 2004-2014.
Shu Y; Song Y; Wang D; Greene CM; Moen A; Lee CK; Chen Y; Xu X; McFarland J; Xin L; Bresee J; Zhou S; Chen T; Zhang R; Cox N
BMC Public Health; 2019 May; 19(Suppl 3):520. PubMed ID: 32326921
[TBL] [Abstract][Full Text] [Related]
11. Surveillance for influenza--United States, 1997-98, 1998-99, and 1999-00 seasons.
Brammer TL; Murray EL; Fukuda K; Hall HE; Klimov A; Cox NJ
MMWR Surveill Summ; 2002 Oct; 51(7):1-10. PubMed ID: 12418623
[TBL] [Abstract][Full Text] [Related]
12. Use of antigenic cartography in vaccine seed strain selection.
Fouchier RA; Smith DJ
Avian Dis; 2010 Mar; 54(1 Suppl):220-3. PubMed ID: 20521635
[TBL] [Abstract][Full Text] [Related]
13. Pandemic influenza preparedness (PIP) framework: Progress challenges in improving influenza preparedness response capacities in the Eastern Mediterranean Region, 2014-2017.
Abubakar A; Elkholy A; Barakat A; Shrestha B; Elhakim M; Malik MR; Bergeri I; Samaan G
J Infect Public Health; 2020 Mar; 13(3):446-450. PubMed ID: 30905541
[TBL] [Abstract][Full Text] [Related]
14. Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity.
Innis BL; Berlanda Scorza F; Blum JS; Jain VK; Older Aguilar A; Post DJ; Roberts PC; Wairagkar N; White J; Bresee J
Vaccine; 2019 Aug; 37(35):4823-4829. PubMed ID: 31362819
[TBL] [Abstract][Full Text] [Related]
15. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of candidate vaccine viruses for prepandemic influenza vaccines.
O'Neill E; Donis RO
Curr Top Microbiol Immunol; 2009; 333():83-108. PubMed ID: 19768401
[TBL] [Abstract][Full Text] [Related]
17. Influenza: global surveillance for epidemic and pandemic variants.
Cox NJ; Brammer TL; Regnery HL
Eur J Epidemiol; 1994 Aug; 10(4):467-70. PubMed ID: 7843358
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses.
Kerstetter LJ; Buckley S; Bliss CM; Coughlan L
Front Immunol; 2020; 11():607333. PubMed ID: 33633727
[TBL] [Abstract][Full Text] [Related]
19. Selection of influenza vaccine strains and developing pandemic vaccines.
Wood JM
Vaccine; 2002 Dec; 20 Suppl 5():B40-4. PubMed ID: 12477418
[TBL] [Abstract][Full Text] [Related]
20. Overview of the WHO Global Influenza Programme.
Stöhr K
Dev Biol (Basel); 2003; 115():3-8. PubMed ID: 15088769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
